Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target
Nephron Research Upgrades Bright Health Gr to Buy, Announces $85 Price Target
Nepron Research 將 Bright Health Gr 升級爲買入，宣佈目標
Nephron Research analyst Joshua Raskin upgrades Bright Health Gr (NYSE:BHG) from Hold to Buy and announces $85 price target.
Nepron Research分析師約書亞·拉斯金將Bright Health Gr（紐約證券交易所代碼：BHG）從持有上調至買入，並宣佈了85美元的目標股
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。